Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Trabectedin> ?p ?o. }
- Trabectedin abstract "Trabectedin (also known as ecteinascidin 743 or ET-743) is an anti-tumor drug. It is sold by Zeltia and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U.S. Food and Drug Administration (FDA) have granted orphan drug status to trabectedin for soft tissue sarcomas and ovarian cancer.".
- Trabectedin atcPrefix "L01".
- Trabectedin atcSuffix "CX01".
- Trabectedin casNumber "114899-77-3".
- Trabectedin drugbank "DB05109".
- Trabectedin fdaUniiCode "ID0YZQ2TCP".
- Trabectedin iupacName "(1R,6R,6aR,7R,13S,14S,16R)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydrospiro[6,16-(epithiopropano-oxymethano)-7,13-imino-6aH-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'(2H)-isoquinolin]-5-yl acetate".
- Trabectedin pubchem "108150".
- Trabectedin thumbnail Trabectedin_.png?width=300.
- Trabectedin wikiPageID "8213823".
- Trabectedin wikiPageRevisionID "593208703".
- Trabectedin atcPrefix "L01".
- Trabectedin atcSuffix "CX01".
- Trabectedin bioavailability "Not applicable".
- Trabectedin c "39".
- Trabectedin casNumber "114899".
- Trabectedin chembl "297812".
- Trabectedin chemspiderid "16736970".
- Trabectedin drugbank "DB05109".
- Trabectedin eliminationHalfLife "648000.0".
- Trabectedin excretion "Mostly fecal".
- Trabectedin h "43".
- Trabectedin hasPhotoCollection Trabectedin.
- Trabectedin inchi "1".
- Trabectedin inchikey "AXYPHJWOKPNXAX-IZQXKXCFSA-N".
- Trabectedin iupacName "-6".
- Trabectedin iupharLigand "2774".
- Trabectedin kegg "D06199".
- Trabectedin legalUk "POM".
- Trabectedin licenceEu "Yondelis".
- Trabectedin metabolism "Hepatic".
- Trabectedin molecularWeight "761.84".
- Trabectedin n "3".
- Trabectedin o "11".
- Trabectedin proteinBound "94".
- Trabectedin pubchem "108150".
- Trabectedin routesOfAdministration Intravenous_therapy.
- Trabectedin s "1".
- Trabectedin smiles "CCOc1c5c[C@@H]6COC[C@@]4CCS[C@H]5[C@@H]9N6[C@@H][C@@H]8Cc7ccccc7[C@H]9N8C".
- Trabectedin stdinchi "1".
- Trabectedin stdinchikey "AXYPHJWOKPNXAX-IZQXKXCFBI".
- Trabectedin unii "ID0YZQ2TCP".
- Trabectedin verifiedfields "changed".
- Trabectedin verifiedrevid "470612054".
- Trabectedin subject Category:Acetate_esters.
- Trabectedin subject Category:Alcohols.
- Trabectedin subject Category:Antineoplastic_drugs.
- Trabectedin subject Category:Orphan_drugs.
- Trabectedin subject Category:Phenol_ethers.
- Trabectedin subject Category:Phenols.
- Trabectedin type Abstraction100002137.
- Trabectedin type AcetateEsters.
- Trabectedin type Agent114778436.
- Trabectedin type Alcohol107884567.
- Trabectedin type Alcohols.
- Trabectedin type Beverage107881800.
- Trabectedin type CausalAgent100007347.
- Trabectedin type Chemical114806838.
- Trabectedin type Compound114818238.
- Trabectedin type Drug103247620.
- Trabectedin type DrugOfAbuse103248958.
- Trabectedin type Element114840755.
- Trabectedin type Ester114850483.
- Trabectedin type Fluid114939900.
- Trabectedin type Food100021265.
- Trabectedin type Liquid114940386.
- Trabectedin type Material114580897.
- Trabectedin type Matter100020827.
- Trabectedin type OrganicCompound114727670.
- Trabectedin type Part113809207.
- Trabectedin type Phenol114989545.
- Trabectedin type PhenolEthers.
- Trabectedin type Phenols.
- Trabectedin type PhysicalEntity100001930.
- Trabectedin type Quintessence114847103.
- Trabectedin type Relation100031921.
- Trabectedin type Substance100019613.
- Trabectedin type Substance100020090.
- Trabectedin type Drug.
- Trabectedin type DrugProduct.
- Trabectedin type FunctionalSubstance.
- Trabectedin comment "Trabectedin (also known as ecteinascidin 743 or ET-743) is an anti-tumor drug. It is sold by Zeltia and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U.S.".
- Trabectedin label "Ecteinascidin 743".
- Trabectedin label "Trabectedin".
- Trabectedin label "Trabectedina".
- Trabectedin label "Trabectedina".
- Trabectedin label "Trabectedina".
- Trabectedin label "Trabektedyna".
- Trabectedin label "トラベクテジン".
- Trabectedin sameAs Ecteinascidin_743.
- Trabectedin sameAs Trabectedina.
- Trabectedin sameAs Trabectedina.
- Trabectedin sameAs トラベクテジン.
- Trabectedin sameAs Trabektedyna.
- Trabectedin sameAs Trabectedina.
- Trabectedin sameAs m.026wdkz.
- Trabectedin sameAs Q2637746.
- Trabectedin sameAs Q2637746.
- Trabectedin sameAs Trabectedin.
- Trabectedin wasDerivedFrom Trabectedin?oldid=593208703.
